Effects of linagliptin (LINA) versus glimepiride (GLIM) on cognitive performance in type 2 diabetes: the CAROLINA COGNITION study

被引：0
|
作者：
Biessels, G. J. [1 ]
Verhagen, C. [1 ]
Janssen, J. [1 ,2 ]
van den Berg, E. [1 ,3 ]
Passera, A. [4 ]
Wallenstein, G. [5 ]
Zinman, B. [6 ]
Espeland, M. E. [7 ]
Johansen, O. E. [8 ]
机构：
[1] UMC Utrecht Brain Ctr, Utrecht, Netherlands
[2] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] UMC, Erasmus MC, Rotherdam, Netherlands
[4] HMS Analyt Software GmbH, Sulzbach, Germany
[5] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[6] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[7] Wake Forest Sch Med, Winston Salem, NC 27101 USA
[8] Boehringer Ingelheim GmbH & Co KG, Asker, Norway
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
583
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [21] Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes
    Van Gaal, L.
    Garvey, W. T.
    Leiter, L. A.
    Vijapurkar, U.
    List, J.
    Cuddihy, R.
    Ren, J.
    Davies, M. J.
    DIABETOLOGIA, 2017, 60 : S413 - S414
  • [22] Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
    Biessels, Geert Jan
    Verhagen, Chloe
    Janssen, Jolien
    van den Berg, Esther
    Zinman, Bernard
    Rosenstock, Julio
    George, Jyothis T.
    Passera, Anna
    Schnaidt, Sven
    Johansen, Odd Erik
    DIABETES CARE, 2019, 42 (10) : 1930 - 1938
  • [23] Effects of Teneligliptin (Teneli) on Glycemic Indices in Type 2 Diabetes (T2DM) Subjects Uncontrolled with Metformin (Met) and Glimepiride (Glim) Combination
    Mahapatra, Hariballav
    Mishra, Susant
    Khuntia, Monalisa
    Jena, Biswaranjan
    Das, Sreeya
    Jena, Apurba R.
    Padhi, Rajesh K.
    Sahoo, Abhay K.
    Mahapatra, Ramaballav
    Mahapatra, Laxminarayan
    DIABETES, 2018, 67
  • [24] Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
    Takashi Kadowaki
    Guang Wang
    Julio Rosenstock
    Daisuke Yabe
    Yongde Peng
    Keizo Kanasaki
    Yiming Mu
    Michaela Mattheus
    Annett Keller
    Tomoo Okamura
    Odd Erik Johansen
    Nikolaus Marx
    Diabetology International, 2021, 12 : 87 - 100
  • [25] Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial (vol 322, pg 1155, 2019)
    Rosenstock, J.
    Kahn, S. E.
    Johansen, O. E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2138 - 2138
  • [26] Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
    Kadowaki, Takashi
    Wang, Guang
    Rosenstock, Julio
    Yabe, Daisuke
    Peng, Yongde
    Kanasaki, Keizo
    Mu, Yiming
    Mattheus, Michaela
    Keller, Annett
    Okamura, Tomoo
    Johansen, Odd Erik
    Marx, Nikolaus
    DIABETOLOGY INTERNATIONAL, 2021, 12 (01) : 87 - 100
  • [27] Efficacy and safety of glimepiride (GLIM) in patients with type 2 diabetes uncontrolled on metformin (MET)/thiazolidinedione (TZD) combination therapy
    Roberts, VL
    Stewart, J
    Issa, M
    Lake, B
    Melis, R
    DIABETES, 2004, 53 : A144 - A144
  • [28] Linagliptin vs. Placebo Followed by Glimepiride in Type 2 Diabetes Patients With Moderate to Severe Renal Impairment
    Laakso, Markku
    Rosenstock, Julio
    Groop, Per-Henrik
    Hehnke, Uwe
    Tamminen, Ilkka
    Patel, Sanjay
    Von Eynatten, Maximilian
    Woerle, Hans-Juergen
    DIABETES, 2013, 62 : A281 - A282
  • [29] The Effects of Type 2 Diabetes on Cognitive Performance: A Review of Reviews
    Sola, Teppo
    Sola, Fanny-Maria
    Jehkonen, Mervi
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2024, 31 (06) : 944 - 958
  • [30] Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial
    Espeland, Mark A.
    Pratley, Richard E.
    Rosenstock, Julio
    Kadowaki, Takashi
    Seino, Yutaka
    Zinman, Bernard
    Marx, Nikolaus
    McGuire, Darren K.
    Andersen, Knut Robert
    Mattheus, Michaela
    Keller, Annett
    Weber, Maria
    Johansen, Odd Erik
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 569 - 580
12345